Monday, November 30, 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV.

from Moneycontrol Business News https://ift.tt/33u15rC

No comments:

Post a Comment

Global Market Today: Asian stocks gain, dollar wobbles as Trump extends Iran ceasefire

U.S. stock futures rose and the dollar wavered after President Trump announced an indefinite extension of the Iran ceasefire, buoying market...